Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising chronic diseases and geriatric population
3.2.1.2 Increasing vaccination initiatives
3.2.1.3 Growing technology advancement focusing on patient safety
3.2.1.4 Rise in biologics and biosimilars research activities
3.2.2 Industry pitfalls & challenges
3.2.2.1 High risk of needlestick injuries
3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Preparation, 2021 – 2032 ($ Mn and Units)
5.1 Key trends
5.2 Ready to use (RTU)
5.3 Ready to sterilize (RTS)
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn and Units)
6.1 Key trends
6.2 Small molecules
6.3 Biologics
6.4 Diagnostics
Chapter 7 Market Estimates and Forecast, By Material, 2021 – 2032 ($ Mn and Units)
7.1 Key trends
7.2 Glass
7.3 Plastic/ polymers
Chapter 8 Market Estimates and Forecast, By Size, 2021 – 2032 ($ Mn and Units)
8.1 Key trends
8.2 <1 ml
8.3 1 ml - 2 ml
8.4 3 ml - 5 ml
8.5 6 ml - 10 ml
8.6 10 - 20 ml
8.7 20 - 30 ml
8.8 >30 ml
Chapter 9 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn and Units)
9.1 Key trends
9.2 Hospitals & clinics
9.3 Pharma & biotech companies
9.4 Contract development and manufacturing organizations (CDMOs)
9.5 Diagnostic laboratories
9.6 Other end users
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn and Units)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
Chapter 11 Company Profiles
11.1 Becton, Dickinson and Company (BD)
11.2 Cardinal Health
11.3 Corning
11.4 Daikyo Seiko
11.5 DWK Life Sciences
11.6 Gerresheimer AG
11.7 ICU Medical
11.8 Mitsubishi Gas Chemical Company
11.9 Nipro
11.10 SCHOTT Pharma (SCHOTT Group)
11.11 Shandong Province Medicinal Glass
11.12 SHIOTANI GLASS
11.13 Terumo
11.14 Weigao Group
11.15 West Pharmaceutical Services
